Novo Nordisk shares dive 9% after heart medicine fails trial

Shares of Novo Nordisk nosedived as much as 10% after the drugmaker said a late-stage heart drug trial failed to reduce major cardiovascular events compared to a placebo. While the experimental medicine, ziltivekimab, did show some biological effect, it didn’t translate into a statistically meaningful reduction in so-called MACE, defined as cardiovascular death, non-fatal heart attack…

Read More

Apple drops 7%, Amazon surges 12% after earnings

Amazon shares surged on Friday while Apple dropped as investors reacted starkly differently to their June quarter earnings reports. Shares of Amazon were 12% higher in premarket trading, while Apple fell 7%. Amazon was nearly 4% higher at Thursday’s close while Apple was down by more than 1%. Both companies reported their June quarter earnings…

Read More

AI demand collides with natural disaster

Deadly storms that have disrupted copper mines in Chile could amplify market strains, strategists say, as the U.S. and China battle for supply of the critical industrial metal, in turn pushing prices higher. Although the immediate outages appear limited, mining disruption in Chile — which accounts for more than a fifth of global copper production…

Read More